Authors:
Butelman, ER
Ko, MCH
Traynor, JR
Vivian, JA
Kreek, MJ
Woods, JH
Citation: Er. Butelman et al., GR89,696: A potent kappa-opioid agonist with subtype selectivity in rhesusmonkeys, J PHARM EXP, 298(3), 2001, pp. 1049-1059
Citation: Er. Butelman et Mj. Kreek, kappa-Opioid receptor agonist-induced prolactin release in primates is blocked by dopamine D-2-like receptor agonists, EUR J PHARM, 423(2-3), 2001, pp. 243-249
Citation: Er. Butelman et al., Effects of E-2078, a stable dynorphin A(1-8) analog, on sedation and serumprolactin levels in rhesus monkeys, PSYCHOPHAR, 147(1), 1999, pp. 73-80
Authors:
Butelman, ER
Vivian, JA
Yu, J
Kreek, MJ
Woods, JH
Citation: Er. Butelman et al., Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys, PSYCHOPHAR, 143(2), 1999, pp. 190-196
Authors:
Ko, MCH
Johnson, MD
Butelman, ER
Willmont, KJ
Mosberg, HI
Woods, JH
Citation: Mch. Ko et al., Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys, J PHARM EXP, 291(3), 1999, pp. 1113-1120
Citation: Mc. Ko et al., Activation of peripheral kappa opioid receptors inhibits capsaicin-inducedthermal nociception in rhesus monkeys, J PHARM EXP, 289(1), 1999, pp. 378-385
Citation: Cm. Campbell et al., Effects of (+)-HA-966, CGS-19755, phencyclidine, and dizocilpine on repeated acquisition of response chains in pigeons: Systemic manipulation of central glycine sites, J PHARM EXP, 289(1), 1999, pp. 521-527
Citation: Er. Butelman et al., Apparent efficacy of kappa-opioid receptor ligands on serum prolactin levels in rhesus monkeys, EUR J PHARM, 383(3), 1999, pp. 305-309